Perioperative outcomes of robotic and laparoscopic adrenalectomy: a large international multicenter experience
- 1 April 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Surgical Endoscopy
- Vol. 35 (4), 1801-1807
- https://doi.org/10.1007/s00464-020-07578-5
Abstract
Background The aim of the study was to describe the surgical outcomes of a retrospective series of consecutive patients treated with laparoscopic and robotic approach for adrenal masses in two tertiary referral centers. Methods We retrospectively gathered data of 477 patients submitted to adrenalectomy performed at two Institutions from March 2008 to February 2018 by six highly experienced surgeons. We excluded from the analysis 43 patients that had an open approach for tumors or for anesthetic contraindications to minimally invasive surgery (MIS). Patients were selected for surgery after a radiologic and an endocrinology work up. Preoperative, perioperative and postoperative data were recorded. Results Overall, 477 patients were included in the study. The robotic and the laparoscopic group included 110 and 367 patients, respectively. The preoperative characteristics were similar in both groups except for ASA score with a median (IQR) of 3 and 2 in the robotic and in the laparoscopic group, respectively (p = 0.03). Tumor size of adrenal tumors treated robotically (4, IQR 2.6-6 cm) was significantly larger than those treated laparoscopically (3, IQR 2.3-4.1 cm) (p = 0.01). The intraoperative complication rates were similar between robotic and laparoscopic groups (6.3% and 6%, respectively). The postoperative complication rate was 5.4% for robotic group and similarly 3.5% for laparoscopic adrenalectomy strategy. We analyzed the tumor >= 6 cm, with 29 patients in the robotic group and 43 in the laparoscopic one, with an overall complication rate of 19.5%. At multivariable analyses tumor size (OR 1.287; CI 1.128-1.468; p < 0.001) was the only independent predictor of overall complication. Conclusion Adrenal tumors can be safely treated either by robotic or laparoscopic strategy. MIS seems to be feasible also in larger adrenal masses (>= 6 cm). Tumor size represents the only predictive factors for overall complication.This publication has 19 references indexed in Scilit:
- Comparative Efficacy of Laparoscopic Versus Robotic Adrenalectomy for Adrenal MalignancyUrology, 2018
- The age of robotic surgery - Is laparoscopy dead?Arab Journal of Urology, 2018
- Laparoscopic versus robotic adrenalectomy: a review of the national inpatient sampleJournal of Robotic Surgery, 2018
- Adrenalectomy: indications and options for treatmentUpdates in Surgery, 2017
- International Consultation on Urological Diseases and European Association of Urology International Consultation on Minimally Invasive Surgery in Urology: laparoscopic and robotic adrenalectomyBJU International, 2016
- Improving Minimally Invasive Adrenalectomy: Selection of Optimal Approach and Comparison of OutcomesWorld Journal of Surgery, 2016
- SAGES guidelines for minimally invasive treatment of adrenal pathologySurgical Endoscopy, 2013
- Robotic versus laparoscopic adrenalectomy: a comparative study in a high-volume centerSurgical Endoscopy, 2012
- Laparoscopic Adrenalectomy: New Gold StandardWorld Journal of Surgery, 1999
- Laparoscopic Adrenalectomy in Cushing's Syndrome and PheochromocytomaThe New England Journal of Medicine, 1992